Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP362384.RAl6L4AYkgchLQXC9hjI_iaXC7jeT9n5aZRodndJki01k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP362384.RAl6L4AYkgchLQXC9hjI_iaXC7jeT9n5aZRodndJki01k130_assertion type Assertion NP362384.RAl6L4AYkgchLQXC9hjI_iaXC7jeT9n5aZRodndJki01k130_head.
- NP362384.RAl6L4AYkgchLQXC9hjI_iaXC7jeT9n5aZRodndJki01k130_assertion description "[We pharmacologically characterized pituitary adenylate cyclase-activating polypeptides (PACAPs), vasoactive intestinal peptide (VIP) and the VPAC(1), VPAC(2) and PAC(1) receptors in human meningeal (for their role in migraine) and coronary (for potential side effects) arteries.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP362384.RAl6L4AYkgchLQXC9hjI_iaXC7jeT9n5aZRodndJki01k130_provenance.
- NP362384.RAl6L4AYkgchLQXC9hjI_iaXC7jeT9n5aZRodndJki01k130_assertion evidence source_evidence_literature NP362384.RAl6L4AYkgchLQXC9hjI_iaXC7jeT9n5aZRodndJki01k130_provenance.
- NP362384.RAl6L4AYkgchLQXC9hjI_iaXC7jeT9n5aZRodndJki01k130_assertion SIO_000772 20974589 NP362384.RAl6L4AYkgchLQXC9hjI_iaXC7jeT9n5aZRodndJki01k130_provenance.
- NP362384.RAl6L4AYkgchLQXC9hjI_iaXC7jeT9n5aZRodndJki01k130_assertion wasDerivedFrom befree-20150227 NP362384.RAl6L4AYkgchLQXC9hjI_iaXC7jeT9n5aZRodndJki01k130_provenance.
- NP362384.RAl6L4AYkgchLQXC9hjI_iaXC7jeT9n5aZRodndJki01k130_assertion wasGeneratedBy ECO_0000203 NP362384.RAl6L4AYkgchLQXC9hjI_iaXC7jeT9n5aZRodndJki01k130_provenance.